Volumetric modulated arc radiotherapy sparing the thyroid gland for early‑stage glottic cancer: A dosimetrical analysis

Kim,Eun Seok; Yeo,Seung‑Gu

doi:10.3892/ol.2014.2039

Volumetric modulated arc radiotherapy sparing the thyroid gland for early‑stage glottic cancer: A dosimetrical analysis

Authors:
- Eun Seok Kim
- Seung‑Gu Yeo
View Affiliations

Affiliations: Department of Radiation Oncology, Soonchunhyang University College of Medicine, Cheonan, Chungnam 330‑721, Republic of Korea
Published online on: April 4, 2014 https://doi.org/10.3892/ol.2014.2039
Pages: 1987-1991

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Previous studies on advanced radiotherapy (RT) techniques for early stage glottic cancer have focused on sparing the carotid artery. However, the aim of the present study was to evaluate the dosimetric advantages of volumetric modulated arc therapy (VMAT) in terms of sparing the thyroid gland in early‑stage glottic cancer patients. In total, 15 cT1N0M0 glottic cancer patients treated with definitive RT using VMAT were selected, and for dosimetric comparison, a conventional RT plan comprising opposed‑lateral wedged fields was generated for each patient. The carotid artery, thyroid gland and spinal cord were considered organs at risk. The prescription dose was 63 Gy at 2.25 Gy per fraction. For the thyroid gland and carotid artery, all compared parameters were significantly lower with VMAT compared with conventional RT. For the thyroid gland, the median reduction rates of the mean dose (Dmean), the volume receiving ≥30% of the prescription dose (V30) and the V50 were 32.6, 40.9 and 46.0%, respectively. The Dmean was 14.7±2.6 Gy when using VMAT compared with 22.2±3.9 Gy when using conventional RT. The differences between the techniques in terms of planning target volume coverage and dose homogeneity were not significant. When considering a recent normal tissue complication probability model, which indicated the mean thyroid gland dose as the most significant predictor of radiation‑induced hypothyroidism, the dosimetric advantage shown in this study may be valuable in reducing hypothyroidism following RT for early stage glottic cancer patients.

View Figures

View References

1	Higgins KM, Shah MD, Ogaick MJ and Enepekides D: Treatment of early-stage glottic cancer: meta-analysis comparison of laser excision versus radiotherapy. J Otolaryngol Head Neck Surg. 38:603–612. 2009.PubMed/NCBI
2	Khan MK, Koyfman SA, Hunter GK, Reddy CA and Saxton JP: Definitive radiotherapy for early (T1-T2) glottic squamous cell carcinoma: a 20 year Cleveland clinic experience. Radiat Oncol. 7:1932012.PubMed/NCBI
3	Mendenhall WM, Amdur RJ, Morris CG and Hinerman RW: T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol. 19:4029–4036. 2001.PubMed/NCBI
4	Feigenberg SJ, Lango M, Nicolaou N and Ridge JA: Intensity-modulated radiotherapy for early larynx cancer: is there a role? Int J Radiat Oncol Biol Phys. 68:2–3. 2007. View Article : Google Scholar : PubMed/NCBI
5	Gomez D, Cahlon O, Mechalakos J and Lee N: An investigation of intensity-modulated radiation therapy versus conventional two-dimensional and 3D-conformal radiation therapy for early stage larynx cancer. Radiat Oncol. 5:742010. View Article : Google Scholar : PubMed/NCBI
6	Rosenthal DI, Fuller CD, Barker JL Jr, et al: Simple carotid-sparing intensity-modulated radiotherapy technique and preliminary experience for T1-2 glottic cancer. Int J Radiat Oncol Biol Phys. 77:455–461. 2010. View Article : Google Scholar : PubMed/NCBI
7	Chera BS, Amdur RJ, Morris CG and Mendenhall WM: Carotid-sparing intensity-modulated radiotherapy for early-stage squamous cell carcinoma of the true vocal cord. Int J Radiat Oncol Biol Phys. 77:1380–1385. 2010. View Article : Google Scholar : PubMed/NCBI
8	Atalar B, Gungor G, Caglar H, Aydin G, Yapici B and Ozyar E: Use of volumetric modulated arc radiotherapy in patients with early stage glottic cancer. Tumori. 98:331–336. 2012.PubMed/NCBI
9	Camingue P, Christian R, Ng D, Williams P, Amin M and Roniger DL: Comparison of external beam treatment techniques for T1-2, N0, M0 glottic cancers. Med Dosim. 37:221–224. 2012. View Article : Google Scholar : PubMed/NCBI
10	Riegel AC, Antone J and Schwartz DL: Comparative dosimetry of volumetric modulated arc therapy and limited-angle static intensity-modulated radiation therapy for early-stage larynx cancer. Med Dosim. 38:66–69. 2013.
11	Dorresteijn LD, Kappelle AC, Boogerd W, et al: Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years. J Clin Oncol. 20:282–288. 2002.PubMed/NCBI
12	Smith GL, Smith BD, Buchholz TA, et al: Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy. J Clin Oncol. 26:5119–5125. 2008. View Article : Google Scholar : PubMed/NCBI
13	Mercado G, Adelstein DJ, Saxton JP, Secic M, Larto MA and Lavertu P: Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma. Cancer. 92:2892–2897. 2001. View Article : Google Scholar : PubMed/NCBI
14	Tell R, Lundell G, Nilsson B, Sjödin H, Lewin F and Lewensohn R: Long-term incidence of hypothyroidism after radiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys. 60:395–400. 2004. View Article : Google Scholar : PubMed/NCBI
15	Boomsma MJ, Bijl HP and Langendijk JA: Radiation-induced hypothyroidism in head and neck cancer patients: a systematic review. Radiother Oncol. 99:1–5. 2011. View Article : Google Scholar : PubMed/NCBI
16	Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL and Trotti A: AJCC Cancer Staging Manual. 7th edition. Springer; New York, NY: 2010
17	Verbakel WF, Cuijpers JP, Hoffmans D, Bieker M, Slotman BJ and Senan S: Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study. Int J Radiat Oncol Biol Phys. 74:252–259. 2009. View Article : Google Scholar : PubMed/NCBI
18	Emami B, Lyman J, Brown A, et al: Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 21:109–122. 1991. View Article : Google Scholar : PubMed/NCBI
19	Marks LB, Yorke ED, Jackson A, et al: Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys. 76(Suppl 3): S10–S19. 2010. View Article : Google Scholar : PubMed/NCBI
20	Boomsma MJ, Bijl HP, Christianen ME, et al: A prospective cohort study on radiation-induced hypothyroidism: development of an NTCP model. Int J Radiat Oncol Biol Phys. 84:e351–e356. 2012. View Article : Google Scholar : PubMed/NCBI
21	Vanderpump MP and Tunbridge WM: Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid. 12:839–847. 2002. View Article : Google Scholar : PubMed/NCBI
22	Bakhshandeh M, Hashemi B, Mahdavi SR, Nikoofar A, Edraki HR and Kazemnejad A: Evaluation of thyroid disorders during head-and-neck radiotherapy by using functional analysis and ultrasonography. Int J Radiat Oncol Biol Phys. 83:198–203. 2012. View Article : Google Scholar : PubMed/NCBI
23	Kumar S, Moorthy R, Dhanasekar G, Thompson S and Griffiths H: The incidence of thyroid dysfunction following radiotherapy for early stage carcinoma of the larynx. Eur Arch Otorhinolaryngol. 268:1519–1522. 2011. View Article : Google Scholar : PubMed/NCBI
24	Gianicolo ME, Gianicolo EA, Tramacere F, Andreassi MG and Portaluri M: Effects of external irradiation of the neck region on intima media thickness of the common carotid artery. Cardiovasc Ultrasound. 8:82010. View Article : Google Scholar : PubMed/NCBI
25	Swisher-McClure S, Mitra N, Lin A, et al: Risk of fatal cerebrovascular accidents after external beam radiation therapy for early stage glottic larynx cancer. Head Neck. Apr 18–2013.(Epub ahead of print). View Article : Google Scholar
26	Martin JD, Buckley AR, Graeb D, Walman B, Salvian A and Hay JH: Carotid artery stenosis in asymptomatic patients who have received unilateral head-and-neck irradiation. Int J Radiat Oncol Biol Phys. 63:1197–1205. 2005. View Article : Google Scholar : PubMed/NCBI
27	McDonald MW, Moore MG and Johnstone PA: Risk of carotid blowout after reirradiation of the head and neck: a systematic review. Int J Radiat Oncol Biol Phys. 82:1083–1089. 2012. View Article : Google Scholar : PubMed/NCBI